Your browser doesn't support javascript.
loading
A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community.
Sever, Mehmet Sükrü; Jager, Kitty J; Vanholder, Raymond; Stengel, Benedicte; Harambat, Jerome; Finne, Patrik; Tesar, Vladimir; Barbullushi, Myftar; Bumblyte, Inga A; Zakharova, Elena; Spasovski, Goce; Resic, Halima; Wiecek, Andrzej; Blankestijn, Peter J; Bruchfeld, Annette; Cozzolino, Mario; Goumenos, Dimitris; Soler, Maria Jose; Rychlík, Ivan; Stevens, Kate I; Wanner, Christoph; Zoccali, Carmine; Massy, Ziad A.
Afiliação
  • Sever MS; Department of Nephrology, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey.
  • Jager KJ; ERA-EDTA Registry, Department of Medical Informatics, Amsterdam Public Health Research Institute Amsterdam, Noord-Holland, The Netherlands.
  • Vanholder R; Nephrology Section, Department of Internal Medicine and Pediatrics, University Hospital Ghent, Gent, Belgium.
  • Stengel B; European Kidney Health Alliance (EKHA), Brussels, Belgium.
  • Harambat J; UVSQ, University Paris-Saclay, University Paris-Sud, Inserm, Clinical Epidemiology Team, CESP, Villejuif, France.
  • Finne P; Pediatric Nephrology Unit, Bordeaux University Hospital, Bordeaux, France.
  • Tesar V; University of Bordeaux, INSERM U1219, Bordeaux, France.
  • Barbullushi M; Helsinki University Central Hospital, Division of Nephrology, Helsinki, 00029, Finland.
  • Bumblyte IA; Department of Nephrology, General University Hospital, Charles University, Prague 12808, Czech Republic.
  • Zakharova E; Department of Nephrology, University of Tirana, Tirana, Albania.
  • Spasovski G; Nephrology Department, Faculty of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Resic H; Nephrology Unit, City Clinical Hospital n.a. s.P. Botkin, 2-nd Botkinsky proezd 5, Moscow, Russia.
  • Wiecek A; Department of Nephrology, University "Sts. Cyril and Methodius", Vodnjanska 17 Skopje, MK, Republic of Macedonia.
  • Blankestijn PJ; Society of Nephrology of Bosnia and Herzegovina, Clinic for Hemodialysis Sarajevo, Clinical Center University of Sarajevo, BA, Bosnia-Herzegovina.
  • Bruchfeld A; Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Katowice, Poland.
  • Cozzolino M; Department of Nephrology, University Medical Center, Utrecht, Utrecht, The Netherlands.
  • Goumenos D; Department of Health, Medicine and Caring Sciences, Linköping University, Faculty of Medicine, Linköping, Sweden.
  • Soler MJ; Department of Renal Medicine, Karolinska University Hospital, CLINTEC KI, Stockholm, SE 141 86, Sweden.
  • Rychlík I; University of Milan, Health Sciences via di rudinì 8 Milano, Lombardia, IT 20122, Italy.
  • Stevens KI; Department of Nephrology, Patras University Hospital, Rio 265 04, Patras, Greece.
  • Wanner C; Department of Nephrology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Zoccali C; Department of Medicine, Third Faculty of Medicine, Charles University and Faculty Hospital Kralovske Vinohrady,Prague, Czech Republic.
  • Massy ZA; The Glasgow Renal and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK.
Clin Kidney J ; 14(1): 23-35, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33570513
ABSTRACT
Chronic kidney disease (CKD) is a major health problem because of its high prevalence, associated complications and high treatment costs. Several aspects of CKD differ significantly in the Eastern European nephrology community compared with Western Europe because of different geographic, socio-economic, infrastructure, cultural and educational features. The two most frequent aetiologies of CKD, DM and hypertension, and many other predisposing factors, are more frequent in the Eastern region, resulting in more prevalent CKD Stages 3-5. Interventions may minimize the potential drawbacks of the high prevalence of CKD in Eastern Europe, which include several options at various stages of the disease, such as raising public, medical personnel and healthcare authorities awareness; early detection by screening high-risk populations; preventing progression and CKD-related complications by training health professionals and patients; promoting transplantation or home dialysis as the preferred modality; disseminating and implementing guidelines and guided therapy and encouraging/supporting country-specific observational research as well as international collaborative projects. Specific ways to significantly impact CKD-related problems in every region of Europe through education, science and networking are collaboration with non-nephrology European societies who have a common interest in CKD and its associated complications, representation through an advisory role within nephrology via national nephrology societies, contributing to the training of local nephrologists and stimulating patient-oriented research. The latter is mandatory to identify country-specific kidney disease-related priorities. Active involvement of patients in this research via collaboration with the European Kidney Patient Federation or national patient federations is imperative to ensure that projects reflect specific patient needs.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article